Company Filing History:
Years Active: 2015-2019
Title: Innovations of Haiying Yang in Pharmaceutical Development
Introduction
Haiying Yang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific health conditions. With a total of 3 patents to his name, Yang's work is focused on advancing therapeutic options for various diseases.
Latest Patents
One of Yang's latest patents involves the development of compounds as Rearranged during Transfection (RET) inhibitors. This invention relates to novel compounds that inhibit the RET kinase, which plays a crucial role in several diseases. The patent outlines pharmaceutical compositions containing these compounds and details processes for their preparation. The therapeutic applications of these compounds are extensive, targeting gastrointestinal disorders such as irritable bowel syndrome (IBS) and various cancers, including non-small cell lung cancer, colorectal cancer, and breast cancer, among others.
Career Highlights
Yang is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient outcomes through targeted therapies.
Collaborations
Yang collaborates with esteemed colleagues, including Hilary Schenck Eidam and Zhen Gong, who contribute to his research and development efforts. Their combined expertise enhances the potential impact of their innovations in the medical field.
Conclusion
Haiying Yang's contributions to pharmaceutical innovations demonstrate his dedication to addressing complex health challenges through targeted therapies. His work continues to pave the way for advancements in treatment options for various diseases.